No CrossRef data available.
Article contents
The use of SSRIs in depressed patients with Parkinson's disease.
Published online by Cambridge University Press: 13 June 2014
Abstract
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
- Type
- Letters to the editor
- Information
- Copyright
- Copyright © Cambridge University Press 1998
References
1.Mannion, L, O'Sullivan, S, Carney, PA, Moran, J. Parkinson's disease exacerbated by paroxetine. Ir J Psych Med 1997; 14: 74–5.CrossRefGoogle Scholar
2.Cummings, JL. Depression and Parkinson's disease: a review. Am J Psychiatry 1992; 149:443–54.Google ScholarPubMed
3.Klaassen, T, Verhey, FR, Sneijders, , et al.Treatment of depression in Parkinson's disease: a meta-analysis. J Neuropsychiatry Clin Neurosci 1995; 7(3): 281–6.Google ScholarPubMed
5.Caley, CF, Friedman, JH. Does fluoxetine exacerbate Parkinson's disease? J Clin Psychiatry 1992; 53: 278–82.Google ScholarPubMed
6.Caley, CF. Extrapyramidal reactions and the selective serotonin reuptake inhibitors. Ann Pharmacother 1997, in print.Google Scholar
7.Mayeux, R, Stern, Y, Williams, JBWet al.Clinical and biochemical features of depression in Parkinson's disease. Am J Psychiatry 1986; 143: 756–9.Google ScholarPubMed
8.Krishnan, KRR, France, RD, Ellinwood, EH. Tricyclic-induced akathisia in patients taking estrogens. Am J Psychiatry 1984; 141: 696–7.Google Scholar
9.Zubenko, GS, Cohen, BM, Lipinski, JF. Antidepressant-related akathisia. j Clin Psychopharmacol 1987; 7: 254–7.CrossRefGoogle ScholarPubMed
10.Lee, HK. Dystonic reactions to amitriptyline and doxepin [letter]. Am J Psychiatry 1988; 145: 649.Google ScholarPubMed
You have
Access